Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Valsartan and Amlodipine on TWEAK, PTX3 and FMD in Diabetic Nephropathy
NCT00921570Phase 4Completed
- Sponsor
- Gulhane School of Medicine
- Start
- Feb 2008
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in diabetic nephropathy (DN) and hypertension (HTN) comparing Amlodipine, Valsartan and Valsartan+Amlodipine (3 arms). Primary endpoint: Flow mediated dilatation at 12 weeks. Started Feb 2008; status: completed.
02
Drugs
valsartanamlodipine
03
Conditions
diabetic nephropathy (DN)hypertension (HTN)
Beyond the preview
Go deeper on NCT00921570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00921570.